Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the im...
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy
About this item
Full title
Author / Creator
Nieto, Juan C. , Roldán, Elisa , Jiménez, Isabel , Fox, Laura , Carabia, Júlia , Ortí, Guillermo , Puigdefàbregas, Lluís , Gallur, Laura , Iacoboni, Gloria , Raheja, Priyanka , Pérez, Ana , Bobillo, Sabela , Salamero, Olga , Palacio, Carlos , Valcárcel, David , Crespo, Marta , Bosch, Francesc and Barba, Pere
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Patients receiving an allogeneic hematopoietic cell transplantation (allo-HCT) after the use of PD-1 inhibitors seem to be at a higher risk of developing acute graft-versus-host disease (aGHVD) through etiopathogenetic mechanisms not fully elucidated. Herein, we investigated the effect of nivolumab administered prior to allo-HCT on the following ea...
Alternative Titles
Full title
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2473246088
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2473246088
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/s41375-020-0851-8
